Literature DB >> 16412601

Sentinel node biopsy in patients with breast cancer--evaluation of exposure to radiation of medical staff.

D Nejc1, M Wrzesień, J Piekarski, J Olszewski, P Pluta, J Kuśmierek, A Jeziorski.   

Abstract

AIM: To measure the absorbed doses of radiation to hands of medical staff performing sentinel node biopsy in breast cancer patients.
METHODS: The study was conducted in 2004, during sentinel node biopsies in 13 breast cancer patients (T1/T2N0). Sentinel nodes were identified with the use of combined radiotracer/blue dye technique (lymphoscintigraphy--99mTc on albumin carrier, surgery after 24 h; blue dye; intraoperative detection of gamma radiation). Highly sensitive thermoluminescent dosimeters (TLD) made of LiF were used to assess the absorbed doses of radiation during the procedure. During lymphoscintigraphy and during surgical procedure a total of 57 TLDs was placed on different parts of hands of medical staff.
RESULTS: Maximal dose recorded during lymphoscintigraphy by TLDs placed on the hands of the physician injecting the radiotracer was 164 microSv. Mean recorded doses were higher for non-dominant hand, especially for distal parts of the index finger, third finger and thumb. During the surgical procedure, TLDs placed on the hands of medical staff recorded much lower doses of radiation than during lymphoscintigraphy. The highest dose was recorded by TLD placed on the pulp of the dominant hand index finger (22 microSv) of the operating surgeon. Mean doses recorded by TLDs placed on the hands of the operating surgeon ranged from 2 to 8 microSv. The absorbed dose of radiation to hands of the scrub nurse was similar to that absorbed to hands of the operating surgeon.
CONCLUSION: The maximum recorded dose during sentinel node biopsy in this study was 2200 times smaller than current 1-year dose limit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412601     DOI: 10.1016/j.ejso.2005.11.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Lymphoscintigraphy and radiation--occupational exposure during sentinel node assay.

Authors:  Elma Kucukalić-Selimović; Amra Skopljak-Beganović; Nermina Beslić; Amela Begić; Sadzida Begović-Hadzimuratović; Zdenka Drazeta
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

2.  In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice.

Authors:  Yong Hyun Jeon; Young-Hwa Kim; Kihwan Choi; Jing Yu Piao; Bo Quan; Yun-Sang Lee; Jae Min Jeong; June-Key Chung; Dong Soo Lee; Myung Chul Lee; Jaetae Lee; Doo Soo Chung; Keon Wook Kang
Journal:  Mol Imaging Biol       Date:  2009-10-15       Impact factor: 3.488

3.  Carcinoma of the breast wire localisation post nuclear medicine sentinel lymph node imaging. Are radiologists receiving a significant dose?

Authors:  R T Meades; W E Svensson; J W Frank; V Gada; G Ralleigh; K Satchithananda; N Barrett; K S Nijran
Journal:  Eur Radiol       Date:  2009-09-18       Impact factor: 5.315

4.  The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Authors:  Francesco Giammarile; Naomi Alazraki; John N Aarsvold; Riccardo A Audisio; Edwin Glass; Sandra F Grant; Jolanta Kunikowska; Marjut Leidenius; Valeria M Moncayo; Roger F Uren; Wim J G Oyen; Renato A Valdés Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

5.  Sentinel lymph node in thyroid tumors - own experience.

Authors:  Krzysztof Kaczka; Bartłomiej Luks; Jakub Jasion; Lech Pomorski
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

Review 6.  The sentinel node in breast cancer.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

7.  Laparoscopic sentinel lymph node mapping after cervical injection of indocyanine green for endometrial cancer - preliminary report.

Authors:  Ewa Surynt; Malgorzata Reinholz-Jaskolska; Mariusz Bidzinski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-14       Impact factor: 1.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.